Patents Assigned to Board of
-
Patent number: 8753605Abstract: In accordance with the purpose(s) of the present disclosure, as embodied and broadly described herein, embodiments of the present disclosure, in one aspect, relate to methods of detecting the over-expression of epidermal growth factor receptor (EGFR) in a subject or sample, methods of diagnosing the presence of one or more angiogenesis related diseases or related biological events in a subject or sample, method of monitoring the progress of one or more angiogenesis related diseases or related biological events in a subject or sample, a 18F-FBEM-CYS-ZEGFR:1907 probe, compositions including a 18F-FBEM-CYS-ZEGFR:1907 probe, and pharmaceutical compositions including a 18F-FBEM-CYS-ZEGFR:1907 probe and the like.Type: GrantFiled: August 30, 2011Date of Patent: June 17, 2014Assignee: The Board of Trustees of the Leland Stanford Junior UniversityInventors: Zhen Cheng, Sanjiv Sam Gambhir, Zheng Miao, Hongguang Liu, Gang Ren
-
Patent number: 8754396Abstract: The present invention provides stretchable, and optionally printable, semiconductors and electronic circuits capable of providing good performance when stretched, compressed, flexed or otherwise deformed. Stretchable semiconductors and electronic circuits of the present invention preferred for some applications are flexible, in addition to being stretchable, and thus are capable of significant elongation, flexing, bending or other deformation along one or more axes. Further, stretchable semiconductors and electronic circuits of the present invention may be adapted to a wide range of device configurations to provide fully flexible electronic and optoelectronic devices.Type: GrantFiled: April 6, 2012Date of Patent: June 17, 2014Assignee: The Board of Trustees of the University of IllinoisInventors: John A. Rogers, Dahl-Young Khang, Yugang Sun, Etienne Menard
-
Patent number: 8753630Abstract: A set of markers for cancer stem cells are provided. The cells can be prospectively isolated or identified from primary tumor samples, and possess the unique properties of cancer stem cells in functional assays for tumor initiation, cancer stem cell self-renewal and differentiation. In addition, cancer stem cells can be used as a predictor for disease progression. The CSC have the phenotype of being positive for expression of CD133, and for EGFRvIII. In another embodiment of the invention, compositions are provided of a bispecific reagent that recognizes CD133 and EGFRvIII, including bispecific antibodies, which are optionally conjugated to a detectable marker, chemotherapeutic agent are radionuclide for imaging or therapy.Type: GrantFiled: February 12, 2009Date of Patent: June 17, 2014Assignee: The Board of Trustees of the Leland Stanford Junior UniversityInventor: Albert J. Wong
-
Patent number: 8753812Abstract: Methods for direct detection of chemical reactions are provided. Electric charge perturbations of the local environment during enzyme-catalyzed reactions are sensed by an electrode system with an immobilized target molecule. The charge perturbation caused by the polymerase reaction can uniquely identify a DNA sequence. The polymerization process generates local perturbations of charge in the solution near the electrode surface and induces a charge in a polarazible gold electrode. This event is detected as a transient current by a voltage clamp amplifier. Detection of single nucleotides in a sequence can be determined by dispensing individual dNTPs to the electrode solution and detecting the charge perturbations. Alternatively, multiple bases can be determined at the same time using a mix of all dNTPs with subsequent analysis of the resulting signal. This technique may be adapted to other reaction determinations, such as enzymatic reactions, other electrode configurations, and other amplifying circuits.Type: GrantFiled: March 29, 2012Date of Patent: June 17, 2014Assignee: The Board of Trustees of the Leland Stanford Junior UniversityInventors: Nader Pourmand, Miloslav Karhanek, Ronald W. Davis
-
Patent number: 8752438Abstract: The present invention is directed to a sensor-enabled geosynthetic material for use in geosynthetic structures and geosyntapes, a method of making the sensor-enabled geosynthetic material and the geosyntapes, and a method of measuring geometric strains of a geosynthetic product made from the sensor-enabled geosynthetic material. The sensor-enabled geosynthetic material includes a polymeric material and an electrically conductive filler. The polymeric material and an electrically conductive filler are combined to provide a sensor-enabled geosynthetic material. The sensor-enabled geosynthetic material having a predetermined concentration of the electrically conductive filler so as to provide the sensor-enabled geosynthetic material with an electrical conductivity and a strain sensitivity within the percolation region or slightly above it.Type: GrantFiled: April 13, 2011Date of Patent: June 17, 2014Assignee: The Board of Regents of the University of OklahomaInventors: Kianoosh Hatami, Brian Grady
-
Patent number: 8754769Abstract: Systems and methods are provided for determining whether and/or when a patient is taking his or her medication and, when appropriate, providing reminders and/or alerts to the patient to improve adherence to a medication regimen. In some embodiments, a medication container is provided that includes a capacitance sensor for sensing the contents of the medication container (e.g., pill count or quantity of liquid medication). The capacitance sensor may include interleaved or interdigitated electrodes oriented vertically, horizontally, or angularly (e.g., diagonally) relative to an axis of the medication container. Reminders and/or alerts to the patient may be triggered based at least in part on the contents of the medication container, when a cap of the container was last opened and/or closed, the location of the medication container, and/or the container's surroundings.Type: GrantFiled: February 25, 2013Date of Patent: June 17, 2014Assignees: AdhereTech Inc., The Board Of Trustees Of The University Of Alabama, For And On Behalf Of The University Of Alabama In HuntsvilleInventors: Joshua Stein, John Langhauser, Michael Morena, Emil Jovanov
-
Patent number: 8754132Abstract: Highly selective 5-HT(2C) receptor agonists receptors are disclosed. The 5-HT(2C) receptor agonists are used in the treatments of disease and conditions wherein modulation of 5-HT(2C) receptors provides a benefit, such as obesity and psychiatric disorders.Type: GrantFiled: May 6, 2013Date of Patent: June 17, 2014Assignees: The Board of Trustees of the University of Illinois, The University of North Carolina at Chapel HillInventors: Alan Kozikowski, Bryan Roth, Andreas Svennebring, Sung Jin Cho
-
Patent number: 8753584Abstract: An electroosmotic (EO) pump is provided that includes a housing having a pump cavity, a porous core medium and electrodes. The porous core medium is positioned within the pump cavity to form an exterior reservoir that extends at least partially about an exterior surface of the porous core medium. The porous core medium has an open inner chamber provided therein. The inner chamber represents an interior reservoir. The electrodes are positioned in the inner chamber and are positioned proximate the exterior surface. The electrodes induce flow of a fluid through the porous core medium between the interior and exterior reservoirs, wherein a gas is generated when the electrodes induce flow of the fluid. The housing has a fluid inlet to convey the fluid to one of the interior reservoir and the exterior reservoir. The housing has a fluid outlet to discharge the fluid from another of the interior reservoir and the exterior reservoir. The housing has a gas removal device to remove the gas from the pump cavity.Type: GrantFiled: November 20, 2013Date of Patent: June 17, 2014Assignees: Illumina, Inc., The Arizona Board of Regents for and on behalf of Arizona State UniveristyInventors: Jonathan Posner, Kamil Salloum, Michal Lebl, Mark Reed, Dale Buermann, Matthew Hage, Bryan Crane, David Heiner, Robert Kain, Michael Schroeder
-
Patent number: 8754084Abstract: The invention provides compounds, compositions and methods for treating myotonic dystrophy. The compounds can selectively bind to CUG repeats in RNA, or to CTG repeats in DNA, and inhibit replication of the nucleic acids.Type: GrantFiled: March 27, 2013Date of Patent: June 17, 2014Assignee: The Board of Trustees of the University of IllinoisInventors: Steven C. Zimmerman, Chun-Ho Wong, Paul J. Hergenrother, Jessie Peh
-
Patent number: 8753897Abstract: Nanoporous materials can be used to enrich samples for subsequent analysis of substances contained in the sample. The method is shown to enrich the yield of species in the low molecular weight proteome, allowing detection of small peptides in the low nanomolar range.Type: GrantFiled: December 20, 2006Date of Patent: June 17, 2014Assignees: The Board of Regents of The University of Texas System, The Ohio State Research FoundationInventors: Mauro Ferrari, Mark Ming-Cheng Cheng, Giovanni Cuda, Marco Gaspari, David Geho, Lance Liotta, Emmanuel Petricoin, Fredika Robertson, Rosa Terracciano
-
Patent number: 8754004Abstract: A method of constructing a phosphorous adsorbing structure includes creating a design model that indicates a percentage of phosphorous removed from a water supply per an amount of a predetermined adsorbent exposed to the water supply based upon an original concentration of phosphorous in the water supply and a retention time of water in the adsorbing structure.Type: GrantFiled: April 16, 2012Date of Patent: June 17, 2014Assignee: The Board of Regents for Oklahoma State UniversityInventor: Chad J. Penn
-
Patent number: 8752555Abstract: A mouth guard including a top mouth piece for engaging the top teeth and a bottom mouth piece for engaging the bottom teeth. The mouth guard also includes a central section having one or more ports for receiving an endotracheal tube, oral gastric tube, and/or oral suction tube. In a first preferred embodiment, a top portion of the central section is attached to the top mouth piece, and a bottom portion of the central section is attached to the bottom mouth piece. In a second preferred embodiment, the entire central section is attached to the bottom mouth piece. The top and bottom mouth pieces are capable of interlocking via male engaging members and female recesses.Type: GrantFiled: December 8, 2010Date of Patent: June 17, 2014Assignee: Board of Trustees of the University of ArkansasInventor: Ricky M. Goldsby
-
Patent number: 8753113Abstract: A removable intraoral device is useful for longitudinal in vivo biofilm research. The device is adapted to allow it to be retained in the oral cavity long enough for biofilm to form and to affect the oral mucosa. The device is readily removable to facilitate longitudinal observations. The device is biostable. The device does not interfere with the animal's daily activities such as eating and drinking. The device can be fabricated and maintained at low cost.Type: GrantFiled: May 19, 2011Date of Patent: June 17, 2014Assignee: Board of Supervisors of Louisiana State University And Agricultural and Mechanical CollegeInventors: Heeje Lee, Alika Yu, Paul Fidel
-
Patent number: 8754124Abstract: The present invention includes bis- and tris-benzamide compounds that block AR signaling and have activity against prostate cancer. Uses for these compounds, and pharmaceutical compositions containing the same, also are provided.Type: GrantFiled: November 21, 2012Date of Patent: June 17, 2014Assignee: Board of Regents, The University of Texas SystemInventors: Jung-Mo Ahn, Ganesh Raj
-
Patent number: 8752328Abstract: The disclosure provides compositions that can be used to make films to increase the efficiency of producing plants and plant parts. The films are designed in part to be environmentally friendly and/or edible. Also provided are methods of using such compositions as well as plants and plant parts comprising such compositions.Type: GrantFiled: April 22, 2010Date of Patent: June 17, 2014Assignee: State of Oregon acting by and through the State Board of Higher Education on behalf of Oregon State UniversityInventors: Clive Kaiser, J. Mark Christensen
-
Patent number: 8753496Abstract: A device for separating and purifying useful quantities of particles comprises: (a) an anolyte reservoir connected to an anode, the anolyte reservoir containing an electrophoresis buffer; (b) a catholyte reservoir connected to a cathode, the catholyte reservoir also containing the electrophoresis buffer; (c) a power supply connected to the anode and to the cathode; (d) a column having a first end inserted into the anolyte reservoir, a second end inserted into the catholyte reservoir, and containing a separation medium; (e) a light source; (f) a first optical fiber having a first fiber end inserted into the separation medium, and having a second fiber end connected to the light source; (g) a photo detector; (h) a second optical fiber having a third fiber end inserted into the separation medium, and having a fourth fiber end connected to the photo detector; and (i) an ion-exchange membrane in the anolyte reservoir.Type: GrantFiled: December 16, 2010Date of Patent: June 17, 2014Assignee: Board of Regents, University of HoustonInventors: George William Jackson, Richard Coale Willson, George Edward Fox
-
Patent number: 8753840Abstract: Disclosed is a modified photoautotrophic bacterium comprising genes of interest that are modified in terms of their expression and/or coding region sequence, wherein modification of the genes of interest increases production of a desired product in the bacterium relative to the amount of the desired product production in a photoautotrophic bacterium that is not modified with respect to the genes of interest.Type: GrantFiled: October 19, 2007Date of Patent: June 17, 2014Assignee: Arizona Board of Regents on behalf of Arizona State UniversityInventor: Willem F. J. Vermaas
-
Publication number: 20140162465Abstract: Apparatuses and methods are provided for electrostatically inhibiting particle contamination of a surface of a process structure, such as a mask or reticle. The apparatuses include a plasma-generating system configured to establish a plasma shield over the surface of the process structure. The plasma shield includes a plasma region and a plasma sheath over the surface of the process structure, with the plasma sheath being disposed, at least partially, adjacent to the surface of the process structure, between the plasma region and the surface of the process structure. The plasma shield facilitates negatively charging particles within the plasma shield, and electrostatically inhibits negatively-charged particle contamination of the surface of the process structure to be protected.Type: ApplicationFiled: December 11, 2012Publication date: June 12, 2014Applicants: BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS, SEMATECH, INC.Inventors: John R. SPORRE, Vibhu JINDAL, David RUZIC
-
Publication number: 20140162960Abstract: Aspects of the invention include compositions and methods for inhibiting the interaction between scaffold proteins and kinases. These compositions and methods find a number of uses including, for example, suppressing tumor growth and metastasis and reducing tumor size and number in a mammal with cancer.Type: ApplicationFiled: April 5, 2012Publication date: June 12, 2014Applicant: The Board of Trustees of the Leland Stanford Junior universityInventors: Katherine LaRoque Jameson, Paul A. Khavari
-
Publication number: 20140163761Abstract: Various embodiments of the present disclosure provide methods, systems, and devices for monitoring one or more utilities consumed within a monitored area. At least certain disclosed methods include detecting an amount of a first utility consumed by a load associated with a device. An amount of a second utility consumed by a load associated with the device is detected. The identity of the device is determined based on the amount of the first and second utility consumed. In further disclosed methods, a utility monitoring method is disclosed that includes measuring an amount of a utility consumed by a first device at a first time and an amount of a utility consumed by a second device at a second time. The identity of the first device is determined based on the measured consumption of the first and second devices at the first and second time. In certain implementations, the electricity meter uses an effective variance analysis of the conductance waveform on an electrical circuit to identify specific appliances.Type: ApplicationFiled: February 10, 2014Publication date: June 12, 2014Applicant: Board of Regents of the Nevada System of Higher Education, on Behalf of the Desert Research InstitInventors: Hampden Kuhns, Peter R. Edwards, George Nikolich, Morien Roberts